Publication Date: September 3, 2014
VaccineNation, a leading provider of news and analysis on the vaccine industry, today announced their ranking of the fifty most influential people in vaccines. From a pool of more than 100 nominations, the publication and its readers ranked PaxVax Chief Technology Officer, Thomas Monath, M.D., as the second most influential person in vaccines.
“On behalf of the entire PaxVax team, we congratulate Tom on this well-deserved recognition of his 30-year career dedicated to fighting infectious disease,” said Kenneth Kelley, Chief Executive Officer of PaxVax. “Tom is a pioneer in the development of vaccines against deadly diseases such as dengue and West Nile. His contributions have been invaluable as we’ve built out the industry’s most robust pipeline of specialty vaccine candidates for the compelling travel vaccine market.”